The global anti-tuberculosis therapeutics market was valued at USD 1,354.00 million in 2024 and is expected to reach USD 2,816.71 million by 2034, growing at a CAGR of 7.60%. Growth is driven by the rising incidence of tuberculosis and increasing research and development activities focused on effective TB treatment solutions. https://www.expertmarketresearch.com/reports/anti-tuberculosis-therapeutics-market